Infection, human immunodeficiency virus i Trials in Atlanta, United States
Conditions / Infection, human immunodeficiency virus i / Atlanta, United States
Infection, human immunodeficiency virus i has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00197145 | Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects | TERMINATED | PHASE3 |
| NCT00094523 | Fosamprenavir Versus Other Protease Inhibitors | COMPLETED | PHASE3 |
| NCT00257621 | GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults | COMPLETED | PHASE2 |
| NCT00046176 | A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients | COMPLETED | PHASE3 |
| NCT00440947 | Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection | COMPLETED | PHASE3 |
| NCT00044577 | New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects | COMPLETED | PHASE3 |
| NCT01227824 | A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily | COMPLETED | PHASE3 |
| NCT00082394 | A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV | COMPLETED | PHASE4 |
| NCT00242840 | Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) | COMPLETED | PHASE3 |
| NCT00102778 | GW873140 In Combination With Kaletra In HIV Infected Subjects | TERMINATED | PHASE2 |